Operating Segments and Geographic Area Information - Summarized Financial Information by Reportable Segments (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended																12 Months Ended
	Dec. 31, 2013		Sep. 30, 2013		Jun. 30, 2013		Mar. 31, 2013		Dec. 31, 2012		Sep. 30, 2012		Jun. 30, 2012		Mar. 31, 2012		Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Segment Reporting Information [Line Items]
Net sales	$ 691,956		$ 648,638		$ 634,197		$ 641,625		$ 687,596		$ 661,226		$ 684,894		$ 711,704		$ 2,616,416	[1]	$ 2,745,420	[1]	$ 2,869,005	[1]
Total segment operating profit																	582,909		406,164		517,794
Total equity in net income of unconsolidated investments																	31,729		38,067		43,754
Total net income attributable to noncontrolling interests																	(26,663)		(18,591)		(28,083)
Segment income:																	535,191		661,156		712,033
Corporate & other																	86,145	[2]	(123,831)	[2]	(178,568)	[2]
Restructuring and other charges	(33,361)	[3]	0	[3]	0	[3]	0	[3]	(16,982)	[3]	0	[3]	(94,703)	[3]	0	[3]	(33,361)	[3]	(111,685)	[3]	0	[3]
Interest and financing expenses																	(31,559)		(32,800)		(37,574)
Other (expenses) income, net																	(6,923)		1,229		357
Income tax expense																	(136,322)		(82,533)		(104,134)
Net income attributable to Albemarle Corporation	155,933		90,512		82,739		83,987		37,726		109,459		50,089		114,262		413,171		311,536		392,114
Polymer Solutions
Segment Reporting Information [Line Items]
Net sales																	864,388		892,232		1,001,922
Total segment operating profit																	153,747		198,426		243,396
Total equity in net income of unconsolidated investments																	8,875		6,416		7,696
Total net income attributable to noncontrolling interests																	(4,753)		(2,221)		(9,803)
Segment income:																	157,869		202,621		241,289
Catalysts
Segment Reporting Information [Line Items]
Net sales																	1,001,606		1,067,948		1,116,863
Total segment operating profit																	222,749		260,544		290,065
Total equity in net income of unconsolidated investments																	22,854		31,651		36,259
Total net income attributable to noncontrolling interests																	0		0		0
Segment income:																	245,603		292,195		326,324
Fine Chemistry
Segment Reporting Information [Line Items]
Net sales																	750,422		785,240		750,220
Total segment operating profit																	153,629		182,690		162,726
Total equity in net income of unconsolidated investments																	0		0		0
Total net income attributable to noncontrolling interests																	(21,910)		(16,350)		(18,306)
Segment income:																	131,719		166,340		144,420
Total segment operating profit
Segment Reporting Information [Line Items]
Total segment operating profit																	530,125		641,660		696,187
Corporate & other
Segment Reporting Information [Line Items]
Total equity in net income of unconsolidated investments																	0		0		(201)
Total net income attributable to noncontrolling interests																	$ 0		$ (20)		$ 26

[1] No sales in a foreign country exceed 10% of total net sales. Also, net sales are attributed to countries based upon shipments to final destination.

[2] For the years ended December 31, 2013, 2012 and 2011, Corporate and other includes $143.1 million, $(68.0) million and $(89.2) million, respectively, of pension and OPEB plan credits (costs) (including mark-to-market actuarial gains and losses).

[3] See Note 19, “Special Items.”